Skip to content

Rheumatoid Arthritis Through Education and US Study (RAEUS)

Improvement in Patient Awareness and Ability to Assess Disease in Rheumatoid Arthritis: Rheumatoid Arthritis Through Education and US Study (RAEUS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02351401
Acronym
RAEUS
Enrollment
101
Registered
2015-01-30
Start date
2011-11-30
Completion date
2013-10-31
Last updated
2015-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Patients can potentially monitor disease activity of rheumatoid arthritis (RA) through self-assessed swollen joints (clinical synovitis)joint counts but reliability of joint swelling is poor. The objective is to evaluate the use of education by ultrasound feedback on the ability of patients to assess for clinical synovitis swollen joints in RA.

Detailed description

Design: 6-month single centre randomized controlled trial. Patients: established RA. Intervention: education on self-assessment of joints that included initial brief patient training on tender (TJC) and swollen (SJC) joint counts, followed by US feedback every 3 months versus standard care without education. Patient and physician independently performed 28-joint counts at each visit. Outcome variables: (Primary) Percentage of patients with good agreement with physician derived swollen joints (prevalence-adjusted bias adjusted kappa, PABAK\>0.6). Other variables: Agreement in SJC (Bland and Altman 95% limits of agreement), feasibility/patient satisfaction survey and disease activity score (DAS28) at 6 months.

Interventions

BEHAVIORALEducation using ultrasonography as feedback tool

Education using ultrasonography as feedback tool

Sponsors

National University Hospital, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* RA patients fulfilling ACR1987 criteria * adults between age 21 and 80 years

Exclusion criteria

* pregnant * no mental health illness * fit to perform informed consent

Design outcomes

Primary

MeasureTime frame
prevalence-adjusted bias adjusted kappa, PABAK>0.6at 6 months

Secondary

MeasureTime frameDescription
Bland and Altman 95% limits of agreement6 monthsswollen joint count agreement
Level of satisfaction6 monthsLikert response, satisfaction survey
disease activity score in 28 joints (DAS28)6 monthscomposite score that measures disease activity incorporating tender joint count, swollen joint count, erythrocyte sedimentation rate and patient global assessment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026